Latest filing published 07 Jun 2019 for Adma Biologics, INC., €19.3M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Biotest Divestiture Trust: trading record in brief
All filings by Biotest Divestiture Trust on record concern Adma Biologics, Inc. In total, 2 filings cover trades dated from 14 May 2018 to 6 June 2019.
The open-market record consists of 2 sales worth €19.3M, with no purchase. The totals do not cover 1 filing with an undisclosed amount. So far in 2019, the count stands at no purchases and 1 sale.
The newest entry dates from 7 June 2019: an open-market sale of €19.3M, in Adma Biologics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Biotest Divestiture Trust
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,813,954 shares@ US$3.75100.0% of flowCommon StockSEC:0001123292-19-000868:0
- 8,591,160 shares0Non-Voting Common StockSEC:0001123292-18-000892:0
2 of 2 declarations
